

"A world leader in pharmaceutical excipients and biologics delivery systems"
Croda Pharma develops high purity pharmaceutical excipients, vaccine adjuvants, and innovative lipid delivery systems for human and veterinary applications. The company specialises in solving complex drug formulation challenges, helping pharmaceutical developers tackle solubility and stability issues across all administration routes. Established in 1925 as part of Croda International, the company combines deep scientific expertise with world class manufacturing capabilities. Pharmaceutical and biotech companies benefit from tailored excipient solutions, in house formulation support, and GMP grade materials. Croda Pharma enables next generation therapies through smart science and collaborative partnerships.


6027
Team Members
1925
Founded
Biotechnology
Sector
On-Site
Work Environment
A future where every promising therapy reaches patients through breakthrough delivery science, eliminating formulation barriers and enabling the pharmaceutical industry to solve humanity's most pressing health challenges.
At Croda Pharma, our mission is to empower biologics delivery through innovative excipients, adjuvant systems, and lipid platforms that enable pharmaceutical developers to formulate and deliver challenging therapies.